Angiogenesis and diabetes: Different responses to pro-angiogenic factors in the chorioallantoic membrane assay

Molecular Medicine

Volumn 14, Issue 11-12, 2008, Pages 705-714

  Di Marco, Giovana S ^a   Alam, Antoine ^b   Dol, Frédéric ^b   Corvol, Pierre ^a   Gasc, Jean Marie ^a   Larger, Etienne ^a  

^a INSERM   (France)

^b SANOFI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN RECEPTOR; DIPEPTIDYL CARBOXYPEPTIDASE; ENDOTHELIN 1; GROWTH FACTOR; VASCULOTROPIN; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CELL ACTIVATION; CHORIOALLANTOIS; CONTROLLED STUDY; DIABETES MELLITUS; EMBRYO; ENDOTHELIUM CELL; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; IN SITU HYBRIDIZATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; VASCULARIZATION;

ANGIOGENESIS INDUCING AGENTS; ANGIOGRAPHY; ANIMALS; CELL LINE; CHICK EMBRYO; CHICKENS; CHO CELLS; CHORIOALLANTOIC MEMBRANE; CRICETINAE; CRICETULUS; DIABETES MELLITUS; ENDOTHELIN-1; HUMANS; HYPERGLYCEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; PEPTIDYL-DIPEPTIDASE A; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 55849103931     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2008-00054.Di.Marco     Document Type: Article

References (30)

1. Martin A, Komada MR, Sane DC. (2003) Abnormal angiogenesis in diabetes mellitus. Med. Res. Rev. 23:117-45.
2. Waltenberger, J. (2001) Impaired collateral vessel development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc. Res. 49:554-60.
3. Ferrara N, Kerbel RS. (2005) Angiogenesis as a therapeutic target. Nature 438:967-74.
4. de Muinck ED, Simons M. (2004) Re-evaluating therapeutic neovascularization. J. Mol. Cell. Cardiol. 36:25-32.
5. Norhammar A, et al. (2002) Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-4.
6. Boodhwani M, et al. (2007) Functional, cellular, and molecular characterization of the angiogenic response to chronic myocardial ischemia in diabetes. Circulation 116(11 Suppl):I-31-I-37.
7. Brownlee M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-25.
8. Larger E, Marre M, Corvol P, Gasc JM. (2004) Hyperglycemia-induced defects in angiogenesis in the chicken chorioallantoic membrane model. Diabetes 53:752-61.
9. Yonekura K, et al. (1999) UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice. Clin. Cancer Res. 5:2185-91.
10. Cruz A, Parnot C, Ribatti D, Corvol P, Gasc JM. (2001) Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J. Vasc. Res. 38:536-45.
11. Parnot C, et al. (1997) A live-cell assay for studying extracellular and intracellular endothelin-converting enzyme activity. Hypertension 30:837-44.
12. Wei L, et al. (1991) Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes. J. Biol. Chem. 266:5540-6.
13. Sibony M, Commo F, Callard P, Gasc JM. (1995) Enhancement of mRNA in situ hybridization signal by microwave heating. Lab. Invest. 73:586-91.
14. Brand M, et al. (2006) Angiotensinogen modulates renal vasculature growth. Hypertension 47:1067-74.
15. Kempf H, Corvol P, Gasc JM. (1999) Expression of the chicken angiotensin II receptor: atypical pattern compared to its mammalian homologues. Mech. Dev. 84:177-80.
16. Favier J, Plouin PF, Corvol P, Gasc JM. (2002) Angiogenesis and vascular architecture in pheochromocytomas: distinctive traits in malignant tumors. Am. J. Pathol. 161:1235-46.
17. Withy RM, et al. (1992) Growth factors produced by human embryonic kidney cells that influence megakaryopoiesis include erythropoietin, interleukin 6, and transforming growth factor-beta. J. Cell. Physiol. 153:362-72.
18. Carmeliet P. (2005) Angiogenesis in life, disease and medicine. Nature 438:932-6.
19. Forough R, et al. (2003) Cell-based and direct gene transfer-induced angiogenesis via a secreted chimeric fibroblast growth factor-1 (sp-FGF-1) in the chick chorioallantoic membrane (CAM). Angiogenesis 6:47-54.
20. Ribatti D, et al. (1999) Human erythropoietin induces a pro-angiogenic phenotype in cultured endothelial cells and stimulates neovascularization in vivo. Blood 93:2627-36.
21. Sjolie AK, Porta M, Parving HH, Bilous R, Klein R. (2005) The Diabetic Retinopathy Candesartan Trials (DIRECT) Programme: baseline characteristics. J. Renin. Angiotensin Aldosterone Syst. 6:25-32.
22. Bek EL, McMillen MA, Scott P, Angus LD, Shaftan GW. (2002) The effect of diabetes on endothelin, interleukin-8 and vascular endothelial growth factor-mediated angiogenesis in rats. Clin. Sci. 103:424S-429S.
23. Ebrahimian TG, et al. (2005) Dual effect of angiotensin-converting enzyme inhibition on angiogenesis in type 1 diabetic mice. Arterioscler. Thromb. Vasc. Biol. 25:65-70.
24. Le Noble FA, Hekking JW, Van Straaten HW, Slaaf DW, Struyker Boudier HA. (1991) Angiotensin II stimulates angiogenesis in the chorio-allantoic membrane of the chick embryo. Eur. J. Pharmacol. 195:305-6.
25. Rivard A, et al. (1999) Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF. Am. J. Pathol. 154:355-63.
26. Li Y, et al. (2007) In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia. Diabetes. 56:656-65.
27. Skopinski P, et al. (2001) Angiotensin-converting enzyme activity and angiomodulatory effects of sera in patients with diabetic retinopathy. Int. J. Clin. Pharmacol. Res. 21:73-8.
28. Williams JL, et al. (2006) Differential gene and protein expression in abluminal sprouting and intraluminal splitting forms of angiogenesis. Clin. Sci. 110:587-95.
29. Pardanaud L, Eichmann A. (2006) Identification, emergence and mobilization of circulating endothelial cells or progenitors in the embryo. Development 133:2527-37.
30. Ribatti D, Vacca A, Roncali L, Dammacco F. (1996) The chick embryo chorioallantoic membrane as a model for in vivo research on angiogenesis. Int. J. Dev. Biol. 40:1189-97.